Skip to content
OpenCapital
Get started

AbbVie ABBV Enterprise value

Enterprise value at other companies

Eli Lilly logo
Eli LillyLLY
$859.77B+10.6%
Pfizer logo
PfizerPFE
$222.4B+9.2%
Johnson & Johnson logo
Johnson & JohnsonJNJ
$622.06B+50.5%
Amgen logo
AmgenAMGN
$246.43B+9.9%
The Cooper Companies, Inc. logo
The Cooper Companies, Inc.COO
$15.19B-20.2%
Cardinal Health logo
Cardinal HealthCAH
$54.7B+45.4%

Other financials

Income statement

See full
Revenue$15.0B+12.4%
Gross profit$10.8B+15.4%
Operating income$4.0B+6.9%
Net income$695.0M-46.0%
EPS (diluted)$0.39-45.8%

Balance sheet

See full
Cash & equivalents$9.4B+81.5%
Total debt$62.4B+1.8%
Total equity-$6.7B-569%
Total assets$136.46B+0.2%

Cash flow

See full
Operating cash flow$3.8B+134%
CapEx$265.0M+12.8%
Free cash flow$3.6B+155%

Valuation

See full
Market cap$382.49B+3.8%
P/E105.2×+17.4×
P/S6.1×-0.3×

Profitability

See full
Gross margin70.7%0.0pp
Operating margin24.4%—
Net margin5.8%-1.5pp
FCF margin31.8%+5.0pp

Returns & leverage

See full
Return on equity89%+32.7pp
Debt / equity46.6×+38.6×
Current ratio0.8×0.0×

Where this comes from

Calculated from AbbVie’s reported figures.

$403.83Bmarket cap+$62.4Btotal debt−$5.2Bcash and equivalents=$460.96B

The official record: AbbVie’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about AbbVie's enterprise value.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is AbbVie's enterprise value?
AbbVie (ABBV) reported enterprise value of $460.96B in Q4 2025.
How has AbbVie's enterprise value changed year-over-year?
AbbVie's enterprise value increased by 24.7% year-over-year, from $369.75B to $460.96B.
What is the long-term trend for AbbVie's enterprise value?
Over 5 years (2020 to 2025), AbbVie's enterprise value has grown at a 12.2% compound annual growth rate (CAGR), from $259.6B to $460.96B.
What does enterprise value mean?
What it would cost to buy the entire business, debt included and cash netted out.
How do you interpret enterprise value?
The capital-structure-neutral valuation base — used in EV/EBITDA and EV/Sales to compare companies with different leverage on a like-for-like footing.
How does enterprise value compare across companies?
Comparable across non-financial companies via the EV multiples it feeds; not used for banks and insurers.